Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

2026 Beijing International Week for Science Literacy Launched in Beijing

BEIJING, Sept. 27, 2026 /PRNewswire/ -- The 2026 Beijing International Week for Science Literacy opened at the Beijing Science Center, running from September 22 to 26. Representatives of international organizations, universities, science museums and centers, and science communication institutions from 11 countries gathered in Beijing. Focusing on science communication...

2026 IMS | IASO Bio Presented FUCASO China Real-World Data

--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients...
Cision PR Newswire

2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206

— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion...
Cision PR Newswire

SEGI FRESH UNVEILS NEW STORE CONCEPT AND REFRESHED BRAND IDENTITY IN BIDOR

BIDOR, Malaysia, Sept. 26, 2026 /PRNewswire/ -- Segi Fresh, Malaysia's Top 1 Fresh Mart,...
Cision PR Newswire

Art on the Waterfront: The 4th Beijing International Canal Arts Fest Kicks Off in Tongzhou

BEIJING, Sept. 26, 2026 /PRNewswire/ -- The Beijing International Canal Arts Fest is a signature...
Cision PR Newswire

ETFs Unlock Growth in China’s Booming Tech Landscape

China, ASEAN and GCC Advance Cooperative Frameworks to Strengthen Regional Supply Chain Resilience

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ --...

CODIT Launches ‘APEC 2025’ Policy Monitoring Platform

AI-Powered Legislative Insights: CODIT's Global Evidence-Based Policy Institute strengthens policy research and strategy SEOUL, South Korea, May 29,...

AccurEdit Therapeutics’ ART001 Becomes China’s First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

RMAT...

Yum China Announces US$510 Million Share Repurchase Agreements for Second Half of 2025 as Part of Broader Capital Return Plan

SHANGHAI, May 29, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has...
1...3,3013,3023,303...4,393Page 3,302 of 4,393